Learn More
Apexbio Technology LLC NB-598 131060-14-5 10mg

Supplier: Apexbio Technology LLC A364510
NB-598 is a selective inhibitor targeting squalene epoxidase (SE) an enzyme that catalyzes the conversion of squalene into 2 3-oxidosqualene a crucial intermediate step within the cholesterol biosynthesis pathway Through competitive inhibition of SE NB-598 interferes with the metabolic pathway associated with triglyceride synthesis involving downstream intermediates such as farnesol In experimental studies utilizing isolated murine pancreatic islets NB-598 inhibits insulin secretion under basal and glucose-stimulated conditions suggesting a functional relationship between SE activity and insulin release processes Additionally NB-598 exerts inhibitory effects on voltage-dependent calcium channels (CaV channels) pointing to a potential link between SE-mediated lipid metabolism and calcium-related cellular signaling in endocrine research This compound serves as a pharmacological tool in lipid metabolism diabetes and endocrine function studies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.